Category: Support
Beyond Bloating: Practical Ways to Find Relief with Crohn’s
Crohn’s bloating isn’t just discomfort—it’s a complex symptom that affects confidence and daily life. New guidance reveals practical strategies for identifying triggers and finding relief through systematic tracking, lifestyle modifications, and careful communication with your healthcare team.
New Treatment Hope for Fibrostenotic Crohn’s: First Human Trial
Palisade Bio has begun the first human trial of PALI-2108, a new oral treatment specifically designed for fibrostenotic Crohn’s disease that targets scarring rather than just inflammation. This represents a potentially groundbreaking approach for patients whose Crohn’s has progressed to cause intestinal narrowing and strictures.
New Gut Healing Drug Shows Promise for IBD Patients
Palisade Bio has begun testing PALI-2108, a new oral drug designed to repair damaged intestinal barriers in IBD patients. While still in early-stage trials, this approach targets the root cause of gut dysfunction rather than just managing symptoms.
Hope on the Horizon: FDA Approves New IBD Treatment Option
The FDA has approved upadacitinib (Rinvoq) for adults with moderately to severely active Crohn’s disease and ulcerative colitis. This JAK inhibitor offers new hope for IBD patients seeking better symptom control, especially those who haven’t found success with conventional treatments.
The Stress-IBD Connection: What Every Patient Should Know
New expert insights clarify the complex relationship between stress and IBD, explaining how stress can worsen symptoms without actually causing the condition. This understanding has important implications for both diagnosis and treatment approaches.
New Imaging Advances Bring Hope for Better Crohn’s Care
New imaging advances are helping doctors better identify and treat Crohn’s disease strictures, offering hope for more personalized care and reduced uncertainty. These developments could mean clearer answers and better treatment decisions for the IBD community.
Hope on the Horizon: New Treatments Changing Crohn’s Outlook
New market analysis shows Crohn’s treatment options expanding rapidly, with biologic therapies leading a shift toward more targeted, effective care. Here’s what this means for the IBD community and how these developments could change your treatment journey.
Your Body, Your Battle: The Hidden Reality of IBD
A recent health report highlights the growing prevalence of IBD and its comprehensive impact on daily life. We explore what this means for our community and the hope found in both medical advances and shared experiences.
When IBD Becomes a Family Legacy: The Rosenthals’ Three-Generation Story
The Rosenthal family of Ohio shows how three generations affected by IBD can transform shared struggle into community leadership. Their recognition at the Crohn’s & Colitis Foundation gala highlights the power of turning personal experience into advocacy that helps others.
Hope on the Horizon: Global Effort Tackles Pediatric IBD
A groundbreaking global initiative is forming to develop IBD treatments designed specifically for children, bringing together researchers, doctors, and patient advocates from multiple continents. This collaborative effort recognizes that children with IBD need therapies tailored to their unique, developing bodies—not just scaled-down adult treatments.
